Ladirubicin
Ladirubicin (PNU-159548) is a derivative of Daunorubicin (HY-13062A). Ladirubicin exhibits DNA intercalation and DNA alkylating properties, inhibits DNA replication and transcription, causes DNA damage, and thereby exhibits antitumor efficacy. Ladirubicin exhibits the potential to penetrate the blood-brain barrier (BBB) for its high lipophilicity. Ladirubicin exhibits toxicity through suppression of bone marrow activity.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 171047-47-5
- Formule: C29H31NO11S
- Masse moléculaire:601.62
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform DNA/RNA Synthesis
More
Activité biologique
Chemical Information
-
CAS No. 171047-47-5
-
Masse moléculaire 601.62
-
Formule C29H31NO11S
-
SMILES
C[C@H]1[C@@H](OS(C)(=O)=O)[C@@H](N2CC2)C[C@](O1)([H])O[C@@H]3C4=C(O)C(C(C5=CC=CC=C5C6=O)=O)=C6C(O)=C4C[C@](C(C)=O)(O)C3
-
Synonyms
PNU-159548
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)